MAGNA Global’s Post

Looking to cut pharmacy costs for your employees? 🧬 Biosimilars could be the answer! Despite biologics making up 46% of pharmaceutical spending, they're just 2% of prescriptions. Educate your employees about the cost-saving potential of biosimilars and help them unlock significant healthcare savings. Spread the word and share this vital article with them today! 💡 #Biosimilars #HealthcareSavings #PharmacyCosts https://lnkd.in/gJWFtnSW

We organized a "Healthcare Café" in collaboration with other pharmaceutical companies that share our passion for incorporating patient insights into drug discovery. These events empower patients with various health conditions, medical professionals, and pharmaceutical company employees to engage in meaningful dialogue and exchange ideas. The objective is to incorporate patient perspectives early into drug discovery and development. Watch the 3-minute video. https://lnkd.in/e_Xc8iNE

From rapid drug absorption to ease of use for patients, there are many reasons to consider developing an inhaled medicine. With our expanded inhalation study capacity in the U.S. and U.K., you can explore new potentials for your pharmaceutical product, possibly extending its lifespan and patient reach. Learn more about our inhalation testing capabilities and book your study today: https://lnkd.in/gbQ4wNPy #InhalationToxicology #InhalationMedicine #QuickStudyStarts

In the US, the average annual cost of pharmacological treatment for a rare disease patient is $32,000, with costs exceeding $100,000 in one-third of cases. To ensure a more sustainable approach, pharmaceutical companies must prioritize affordability and access. Four key strategies to follow here > https://owy.mn/4ddCrgY #OWHealth #pharma #raredisease

On May 20th, the National Medical Products Administration (NMPA) announced the recent approval of a Class 1 innovative drug, "Pregabalin Benzenesulfonate Capsules" (trade name: Simening), submitted by Haisco Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Haisco"). This medication is used for the treatment of adult diabetic peripheral neuropathic pain. According to the NMPA, Pregabalin Benzenesulfonate is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). The approval of this drug provides a new treatment option for adult patients suffering from diabetic peripheral neuropathic pain. #APIs #Medical #Rawmaterials #Pharma #Medicine #Pharmaceutical

From rapid drug absorption to ease of use for patients, there are many reasons to consider developing an inhaled medicine. With our expanded inhalation study capacity in the U.S. and U.K., you can explore new potentials for your pharmaceutical product, possibly extending its lifespan and patient reach. Learn more about our inhalation testing capabilities and book your study today: https://lnkd.in/gEyMMKph #InhalationToxicology #InhalationMedicine #QuickStudyStarts

An excellent resource for a common counselling topic: how to use heat for muscle pain.

From rapid drug absorption to ease of use for patients, there are many reasons to consider developing an inhaled medicine. With our expanded inhalation study capacity in the U.S. and U.K., you can explore new potentials for your pharmaceutical product, possibly extending its lifespan and patient reach. Learn more about our inhalation testing capabilities and book your study today: https://lnkd.in/ebiDUKNq #InhalationToxicology #InhalationMedicine #QuickStudyStarts

From rapid drug absorption to ease of use for patients, there are many reasons to consider developing an inhaled medicine. With our expanded inhalation study capacity in the U.S. and U.K., you can explore new potentials for your pharmaceutical product, possibly extending its lifespan and patient reach. Learn more about our inhalation testing capabilities and book your study today: https://lnkd.in/eMSMJ6Ve #InhalationToxicology #InhalationMedicine #QuickStudyStarts

Read PwC’s quick reaction and assessment of the recently released IRA Drug Price Negotiation Maximum Fair Prices. Gain valuable insights into the first round of negotiated prices and understand the implications for pharmaceutical organizations and the healthcare landscape. https://pwc.to/3YR8Chq